{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:06:28Z","timestamp":1790629588292,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejso.2013.11.026","type":"journal-article","created":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T10:31:18Z","timestamp":1387017078000},"page":"891-898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: A multicenter study"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Ferrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gadducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Greggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Panuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Scaffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sismondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-5309","authenticated-orcid":false,"given":"N.","family":"Biglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2013.11.026_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007565.pub2","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"10","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejso.2013.11.026_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ejso.2011.08.138","article-title":"Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases","author":"Classe","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/IGC.0b013e31821bb8aa","article-title":"Clinical trials in recurrent ovarian cancer","volume":"21","author":"Friedlander","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.11.026_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2013.11.026_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008765.pub3","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejso.2013.11.026_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/IGC.0b013e31823532ce","article-title":"Extraperitoneal metastases from recurrent ovarian cancer","volume":"22","author":"Robinson","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.11.026_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2006.06.039","article-title":"Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors","volume":"104","author":"Blanchard","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2407-8-367","article-title":"Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome","volume":"8","author":"Legge","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2013.11.026_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1072-7515(03)00234-5","article-title":"Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications","volume":"197","author":"Morice","year":"2003","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2013.11.026_bib10","first-page":"383","article-title":"FIGO staging of ovarian cancer. From FIGO Cancer Committee Staging Announcement","volume":"25","year":"1986","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2013.11.026_bib11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1447-0756.2010.01274.x","article-title":"The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer","volume":"36","author":"Abe","year":"2010","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ejso.2013.11.026_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2007.05.016","article-title":"Ovarian cancer patients with \u201cnode-positive-only\u201d Stage IIIC disease have a more favorable outcome than Stage IIIA\/B","volume":"107","author":"Ferrandina","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ygyno.2006.08.047","article-title":"Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?","volume":"103","author":"Cliby","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2013.11.026_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Benedetti Panici","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2013.11.026_bib16","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1200\/JCO.2005.02.1287","article-title":"Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial","volume":"23","author":"Crawford","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"S3","key":"10.1016\/j.ejso.2013.11.026_bib17","first-page":"599","article-title":"The role of lymphadenectomy in advanced epithelial ovarian cancer in patients with macroscopically complete resection of intraperitoneal disease","volume":"16","author":"Du Bois","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.11.026_bib18","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery in ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejso.2013.11.026_bib19","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/1097-0142(19951101)76:9<1606::AID-CNCR2820760917>3.0.CO;2-H","article-title":"Secondary cytoreductive surgery for recurrent ovarian cancer: a prospective study","volume":"76","author":"Eisenkop","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.11.026_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2007.04.006","article-title":"Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"106","author":"Tebes","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib21","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer","volume":"14","author":"Benedetti Panici","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1525-1438.2007.00929.x","article-title":"Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery","volume":"17","author":"Benedetti Panici","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.11.026_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.21652","article-title":"Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients","volume":"102","author":"Sehouli","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib24","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer \u2013 the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jso.21686","article-title":"Survival after secondary cytoreduction for recurrent ovarian cancer: which are the prognostic factors?","volume":"102","author":"Biliatis","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2010.10.008","article-title":"Surgical management of recurrent ovarian cancer: the advantage of collaborative surgical management and a multidisciplinary approach","volume":"120","author":"Burton","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib27","first-page":"1727","article-title":"A\u00a0mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate","volume":"63","author":"Goldie","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ejso.2013.11.026_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/613980","article-title":"The role of secondary surgery in recurrent ovarian cancer","author":"Lorusso","year":"2012","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/gyno.2001.6232","article-title":"The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2009.11.008","article-title":"The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study","volume":"116","author":"Gadducci","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1525-1438.2002.01096.x","article-title":"Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy","volume":"12","author":"Fujiwara","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.11.026_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2009.04.025","article-title":"Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer","volume":"114","author":"Fotiou","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1245\/ASO.2004.11.023","article-title":"Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes","volume":"11","author":"Uzan","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.11.026_bib34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2006.10.020","article-title":"Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer","volume":"104","author":"Santillan","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313009360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313009360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T02:24:01Z","timestamp":1538965441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798313009360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0748798313009360"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2013.11.026","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2013.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}